Protara Therapeutics, Inc.
TARA· Nasdaq
TARAProtara Therapeutics, Inc.
Filed May 13, 2020 · 10-Q · 43 days after period end · 0001213900-20-011893
| Metric | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|
| Net Income | -$10.06M | -$6.53M | -$6.08M | -$6.50M |
| EPS Diluted | -$1.81 | -$0.58 | -$0.34 | -$0.39 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protara Therapeutics, Inc. · CIK 1359931 · Engraved from SEC EDGAR
ended Mar 31, 2020 · filed May 13, 2020 · 43 d after period end
